Knockout of ykcB, a Putative Glycosyltransferase, Leads to Reduced Susceptibility to Vancomycin in Bacillus subtilis
暂无分享,去创建一个
[1] C. Kaito,et al. Knockout of mlaA increases Escherichia coli virulence in a silkworm infection model , 2022, PloS one.
[2] T. Fujiwara,et al. The Absence of Osmoregulated Periplasmic Glucan Confers Antimicrobial Resistance and Increases Virulence in Escherichia coli , 2021, Journal of Bacteriology.
[3] P. Freemont,et al. Bacillus subtilis YngB contributes to wall teichoic acid glucosylation and glycolipid formation during anaerobic growth , 2020, bioRxiv.
[4] C. Kaito,et al. Animal infection models using non‐mammals , 2020, Microbiology and immunology.
[5] R. Karaman,et al. Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches , 2020, Molecules.
[6] D. Fish,et al. The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2020, Antimicrobial Agents and Chemotherapy.
[7] Tetsuya Hayashi,et al. Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter , 2020, PLoS pathogens.
[8] S. Salipante,et al. Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels. , 2020, The Journal of antimicrobial chemotherapy.
[9] M. Loessner,et al. GtcA is required for LTA glycosylation in Listeria monocytogenes serovar 1/2a and Bacillus subtilis , 2019, bioRxiv.
[10] W. Vollmer,et al. Inactivation of the Monofunctional Peptidoglycan Glycosyltransferase SgtB Allows Staphylococcus aureus To Survive in the Absence of Lipoteichoic Acid , 2018, bioRxiv.
[11] A. Gründling,et al. Discovery of genes required for lipoteichoic acid glycosylation predicts two distinct mechanisms for wall teichoic acid glycosylation , 2018, The Journal of Biological Chemistry.
[12] W. Rose,et al. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus , 2017, Antimicrobial Agents and Chemotherapy.
[13] M. Cancino-Diaz,et al. Staphylococcus epidermidis lipoteichoic acid: exocellular release and ltaS gene expression in clinical and commensal isolates , 2017, Journal of medical microbiology.
[14] C. Gross,et al. Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis. , 2017, Cell systems.
[15] Eleni Karinou,et al. Identification of a Lipoteichoic Acid Glycosyltransferase Enzyme Reveals that GW-Domain-Containing Proteins Can Be Retained in the Cell Wall of Listeria monocytogenes in the Absence of Lipoteichoic Acid or Its Modifications , 2016, Journal of bacteriology.
[16] T. Aoyagi,et al. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis , 2015, Scientific Reports.
[17] A. Tomasz,et al. Mechanisms of vancomycin resistance in Staphylococcus aureus. , 2014, The Journal of clinical investigation.
[18] M. Rybak,et al. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open? , 2013, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[19] G. Kaatz,et al. Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect” , 2013, Antimicrobial Agents and Chemotherapy.
[20] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[21] D. Ward,et al. Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. , 2012, The Journal of infectious diseases.
[22] J. Errington,et al. A widespread family of bacterial cell wall assembly proteins , 2011, The EMBO journal.
[23] Torsten Seemann,et al. Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR , 2011, PLoS pathogens.
[24] L. Cui,et al. Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3 , 2011, Antimicrobial Agents and Chemotherapy.
[25] L. Cui,et al. walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.
[26] M. Ogura,et al. Identification of the sequences recognized by the Bacillus subtilis response regulator YclJ , 2010, Archives of Microbiology.
[27] T. Awasaki,et al. Identification of Lipoteichoic Acid as a Ligand for Draper in the Phagocytosis of Staphylococcus aureus by Drosophila Hemocytes1 , 2009, The Journal of Immunology.
[28] S. McAllister,et al. Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus , 2009, Journal of Clinical Microbiology.
[29] G. Eliopoulos,et al. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. , 2009, The Journal of infectious diseases.
[30] L. Cui,et al. Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.
[31] M. Ogura,et al. Identification of the Sequences Recognized by the Bacillus subtilis Response Regulator YrkP , 2008, Bioscience, biotechnology, and biochemistry.
[32] T. Kohler,et al. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity , 2007, Molecular microbiology.
[33] Benjamin P. Howden,et al. Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia , 2006, Antimicrobial Agents and Chemotherapy.
[34] S. Hamada,et al. Silkworm pathogenic bacteria infection model for identification of novel virulence genes , 2005, Molecular microbiology.
[35] G. Bierbaum,et al. Morphological and Genetic Differences in Two Isogenic Staphylococcus aureus Strains with Decreased Susceptibilities to Vancomycin , 2003, Antimicrobial Agents and Chemotherapy.
[36] Haruo Watanabe,et al. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. , 2002, Microbial pathogenesis.
[37] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[38] R. Jayaswal,et al. Characterization of Passage-Selected Vancomycin-Resistant Staphylococcus aureus Strains of Diverse Parental Backgrounds , 2000, Antimicrobial Agents and Chemotherapy.
[39] C. Walsh,et al. VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function? , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Tomasz,et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. , 1999, The New England journal of medicine.
[41] A. Tomasz,et al. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus , 1997, Journal of bacteriology.
[42] Y. Sadaie,et al. Formation of competent Bacillus subtilis cells , 1983, Journal of bacteriology.
[43] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[44] 橋本 優実. Identification of lipoteichoic acid as a ligand for Draper in the phagocytosis of Staphylococcus aureus by Drosophila hemocytes , 2010 .